2-hydroxy-5-methyl-3-(morpholinomethyl)-benzaldehyde, (I), and 4,4 '-dimethyl-6,6 '-bis(morpholinomethyl)-2,2 '-ethylenedinitrilodimethylidyne)diphenol, (II)
The title compounds, (I) (C13H17NO3) and (II) (C28H38N4O4), are in the mono
clinic.space group P2(1)/c with Z = 4 and 2, respectively. Molecule (II) ha
s a crystallographic centre of inversion. The morpholino ring adopts a chai
r conformation in both with equatorial substituents. Both molecules have an
intramolecular O-H...N bond.